Search Results

GZD824 25mg  | 99.83%

APEXBIO TECHNOLOGY LLC

Bcr-Abl inhibitor,novel orally bioavailable Tyrosine Kinase|Bcr-Abl

More Information Supplier Page

×

GZD824

DCC-2036 (Rebastinib) 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

Bcr-Abl inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

DCC-2036 (Rebastinib)

DCC-2036 (Rebastinib) 5mg  | 98%

APEXBIO TECHNOLOGY LLC

Bcr-Abl inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

DCC-2036 (Rebastinib)

DCC-2036 (Rebastinib) 10mg  | 98%

APEXBIO TECHNOLOGY LLC

Bcr-Abl inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

DCC-2036 (Rebastinib)

GZD824 10mM (in 1mL DMSO)  | 99.83%

APEXBIO TECHNOLOGY LLC

Bcr-Abl inhibitor,novel orally bioavailable Tyrosine Kinase|Bcr-Abl

More Information Supplier Page

×

GZD824

Cabozantinib malate (XL184) 100mg  | 98.1%

APEXBIO TECHNOLOGY LLC

MET andVEGF receptor2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Cabozantinib malate (XL184)

Cabozantinib malate (XL184) 25mg  | 98.1%

APEXBIO TECHNOLOGY LLC

MET andVEGF receptor2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Cabozantinib malate (XL184)

Cabozantinib malate (XL184) 5mg  | 98.1%

APEXBIO TECHNOLOGY LLC

MET andVEGF receptor2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Cabozantinib malate (XL184)

Cabozantinib malate (XL184) 10mM (in 1mL DMSO)  | 98.1%

APEXBIO TECHNOLOGY LLC

MET andVEGF receptor2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Cabozantinib malate (XL184)

Brefeldin A 10mM (in 1mL DMSO)  | 98.73%

APEXBIO TECHNOLOGY LLC

ATPase inhibitor Membrane Transporter/Ion Channel|ATPase

More Information Supplier Page

×

Brefeldin A